Please assess the completion status of the following clinical trial:

Trial Title: Evaluate Pharmacokinetics and Safety of BMS-986177 in Participants With Normal Renal Function and With Moderate or Severe Renal Impairment

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Participants in Groups B and C will be classified by renal function by eGRF at screening and confirmed on Day -1~* Participants in Group A will be healthy participants as determined by no significant deviations in normal medical and surgical history and assessments~* Participants in Group A must have a body mass index of 18.0 to 32.0 kg/m2, inclusive~* Females must be of non-childbearing potential~Exclusion Criteria:~* Participants in Groups B and C cannot have an indwelling catheter for hemodialysis~* Participants in Groups B and C cannot have had, nor be waiting for, an organ transplant~Other protocol defined inclusion and exclusion criteria could apply

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: t

Study Arms:
- Group A (Type: EXPERIMENTAL): Normal Renal Function
- Group B (Type: EXPERIMENTAL): Moderate Renal Impairment
- Group C (Type: EXPERIMENTAL): Severe Renal Impairment

Based on this trial design, predict the completion outcome and termination type (if applicable).